Jinghua Pharmaceutical Group Co Ltd
002349
Company Profile
Business description
Jinghua Pharmaceutical Group Co Ltd is engaged in the pharmaceutical research, development, manufacturing, and trading for active pharmaceutical ingredients, pharmaceutical intermediates, western medicines and proprietary Chinese medicine preparations. The company is also involved in the field of bio-medicine. It sells its products in China and also exports it to international countries.
Contact
No. 9 Xingtai Road
Gangzha Economic Development Zone
Jiangsu Province
Nantong226005
CHNT: +86 51385609118
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,490
Stocks News & Analysis
stocks
After Earnings, is Alphabet stock a buy, a sell, or fairly valued?
With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.
stocks
Moated ASX share crashes amid weak trading update
Bapcor signalled lower underlying profits for fiscal 2025, while an audit cast doubt on the firm’s past earnings.
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,025.40 | 58.70 | 0.65% |
| CAC 40 | 7,857.36 | 56.48 | 0.72% |
| DAX 40 | 24,217.37 | 247.01 | 1.03% |
| Dow JONES (US) | 44,632.99 | 204.57 | -0.46% |
| FTSE 100 | 9,136.32 | 54.88 | 0.60% |
| HKSE | 25,415.94 | 108.51 | -0.43% |
| NASDAQ | 21,098.29 | 80.29 | -0.38% |
| Nikkei 225 | 40,721.01 | 46.46 | 0.11% |
| NZX 50 Index | 12,937.02 | 0.61 | 0.00% |
| S&P 500 | 6,370.86 | 18.91 | -0.30% |
| S&P/ASX 200 | 8,766.50 | 61.90 | 0.71% |
| SSE Composite Index | 3,628.53 | 18.82 | 0.52% |